Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    

SummaryNewsCalendarCompanyFinancials 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in  
Fiscal Period December 201120122013
Sales---
EBITDA65,9-31,7-16,3
Operating profit (EBIT)-50,6-31,8-16,4
Pre-Tax Profit (EBT)-50,5-31,7-16,4
Net income-50,5-31,7-16,4
P/E ratio---
EPS ( $ )-0,84-0,47-0,24
Dividend per Share ( $ )---
Yield---
Reference price ( $ )
Announcement Date03/06/2012
09:05pm
03/07/2013
09:24pm
03/11/2014
08:25pm
Finances - Leverage
Actuals in M $ Estimates in  
Fiscal Period December 201120122013
Debt---
Finance41,128,445,3
Operating income (EBITDA)65,9-31,7-16,3
Leverage
(Debt/EBITDA)
---
Capital Expenditure0,230,030,00
Book Value Per Share (BVPS)0,54 $0,38 $0,55 $
Cash Flow per Share-0,80 $-0,58 $-0,22 $
Announcement Date03/06/2012
09:05pm
03/07/2013
09:24pm
03/11/2014
08:25pm
---
Assessed data source :
© 2017 Thomson Reuters
EPS & Dividend